Formulary Search
A to Z of Drugs : I
Records returned : 114 (on 20 Oct 2025 at 05:10:53).
Show Icon and Status Keys
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
50mg tablets for bone metastases in breast cancer. Specialist initiation and prescribing for at least 1 month before any request is made for primary care prescribing.
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
Used in
- hypercalcaemia of malignancy
- bone metastases
- prevention of skeletal events
Formulary Status :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
150mg tablets
(note - 50mg tablets are not licensed for this indication)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Paediatric consultants only
Formulary Status :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Indication :
Status :
Formulations :
- Gel
Restrictions / Comments:
Important
Preferred
5% gel. This is the least costly option for primary care.
Formulary Status :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
Restricted for patients where an oral NSAID is not suitable.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Preferred
Formulary Status :
Indication :
Status :
Formulations :
- Oro-dispersible tablets
Restrictions / Comments:
Important
Reserved for patients with swallowing difficulties
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Restricted for patients where an oral NSAID is not suitable
Formulary Status :
Indication :
Status :
Formulations :
- Capsules
- Modified release capsules
Restrictions / Comments:
Formulary Status :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
RSFT only - NHSE commissioned
Formulary Status :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
With statin therapy in patients with raised triglycerides
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Intravenous injection (IV)
Restrictions / Comments:
Important
Dabigatran anticoagulant reversal.
RESTRICTED to Haematologists only
Formulary Status :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE - comissioned from specialist centres only. Not provided by any Surrey Heartlands Trusts.
Formulary Status :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
NHSE Specialised Commissioned Services only
Formulary Status :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.
Formulary Status :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Formulary Status :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE Specialist Centres only. Not a service that is provided by any of the Surrey Heartlands Acute Trusts.
NHS England specialist centres only. Not a service that is provided by any of the Surrey Heartlands Acute Trusts
Formulary Status :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Restricted Antimicrobial - requires Microbiology Specialist Approval.
Formulary Status :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Indication :
Status :
Formulations :
- Cream
Restrictions / Comments:
Important
Imiquimod 5% cream
Primary care iniatiation only on recommendation from dermatology specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cream
Restrictions / Comments:
Important
Imiquimod 3.75% cream (Zyclara) - not to be prescribed. The 5% cream is a more cost-effective option.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cream
- Topical solution
Restrictions / Comments:
Important
Imiquimod 5% cream - specialist diagnosis / initiation is usually required. See PAD for the limited circumstances in which initiation may ocurr in Primary Care.
Formulary Status :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Indication: in transit metastases from melanoma
Formulary Status :
Indication :
Status :
Formulations :
- Cream
Restrictions / Comments:
Important
Preferred
Consider if self-care is appropriate
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Prescribing in secondary care is commissioned by NHSE
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhaler (dry powder)
Restrictions / Comments:
Important
LABA monotherapy no longer recommended for asthma or COPD.
Not for initiation in new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Immediate release tablets
Restrictions / Comments:
Important
Preferred
Preferred thiazide diuretic
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Modified-release indpapmide tablets are not a preferred treatment option. Immediate-release tablets are recommended.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
For use in endoscopic procedures.
Formulary Status :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist approval
Formulary Status :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Paediatric consultants only
Formulary Status :
Indication :
Status :
Formulations :
- Capsules
- Capsules (slow release)
Restrictions / Comments:
Important
Only for use in gout.
ASPH restricted to rheumatology only.
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Indication :
Status :
Formulations :
- Liquid
Restrictions / Comments:
Important
Prescribe on advice from specialist e.g. dietitian
500ml presentation for enteral feeding only.
Links :
Indication :
Status :
Formulations :
- Liquid
Restrictions / Comments:
Important
Prescribe on advice from specialist e.g. dietitian
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
For use in ankylosing spondylitis only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Highly specialist centres only
Formulary Status :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
NHSE Specilaist centres only. Not commissioned from any Surrey Heartlands Trusts.
Formulary Status :
Indication :
Status :
Formulations :
- Intravenous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Indication :
Status :
Formulations :
- Intravenous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
For UC & CD. Prescribe by brand
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE Commissioned - Specilaist centres only
Formulary Status :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Dermatology specialist team only.
Formulary Status :
Indication :
Status :
Formulations :
- Intravenous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE Specialist Commissioned services only. Not routinely commissioned.
Formulary Status :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
- Vials
Restrictions / Comments:
Important
For adult patients ONLY
Prescribe by brand and state form.
Initiation by diabetologists only. A minimum prescribing duration of three months by secondary care before transferring to primary care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
- PumpCart
- Vials
Restrictions / Comments:
Important
Biosimilar insulin aspart (Trurapi) should be used in preference to NovoRapid. Prescribe by brand and state form.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
- Vials
Restrictions / Comments:
Important
Preferred
Prescribe by brand and state form. Lower-cost biosimilar. Preferred for new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
Restrictions / Comments:
Important
Initiation by Diabetes team only. Prescribe by brand.
Insulin degludec is available in strengths of 100units/mL and 200units/mL - ensure correct strength is prescribed and dispensed
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
Restrictions / Comments:
Important
Levemir (insulin detemir Penfill / FlexPen) is being discontinued. Supplies are expected to run out by Dec 2026. It is recommended that this is not initiated in new patients.
Patients on these devices will need to be switched to an alternative::
- First line - Semglee pre-filled pens (insulin glargine). No cartridges available.
- Second line - Lantus or Abasaglar cartridges (insulin glargine) or Lantus Solostar pens / Abasaglar Kwikpen (insulin glargine)
See PAD page for further information and switching advice.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
Restrictions / Comments:
Important
Prescribe by brand and state form. Semglee (biosimilar) is a lower cost option for patients using a pre-filled pen.
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
- Vials
Restrictions / Comments:
Important
Prescribe by brand and state form. Semglee (biosimilar) is a lower cost option for patients using a pre-filled pen. Lantus remains an option in existing patients and those preferring a reusable pen.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Pre-filled pen
Restrictions / Comments:
Important
Preferred
Semglee (biosimilar insulin glargine) is the preferred brand for all new patients who require a pre-filled pen.
Prescribe by brand.
Note - Semglee is NOT available as cartridges for use in re-usable insulin pens.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Pre-filled pen
Restrictions / Comments:
Important
Initiation by diabetes consultants or GPs with a specialist interest in diabetes. For use in poorly controlled patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
- Vials
Restrictions / Comments:
Important
Prescribe by brand and state form.
SASH - restricted to diabetes team initiation only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
- Vials
Restrictions / Comments:
Important
Biosimilar insulin Lispro (Admelog).
Prescribe by brand and state form.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
- Vials
Restrictions / Comments:
Important
Prescribe by brand and state form. Admelog (biosimilar insulin lispro) is lower cost and should be considered in preference to Humalog.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
- Vials
Restrictions / Comments:
Important
Prescribe by brand and state form.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Important
Note; Neither Continuous Glucose Monitoring (CGM) nor Omnipod 5 is commissioned for this cohort.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Interferon beta 1a (Avonex, Rebif)
Formulary Status :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Interferon beta 1b (Betaferon, Extavia)
Formulary Status :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Formulary Status :
Indication :
Status :
Formulations :
- Topical solution
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Topical solution
Restrictions / Comments:
Formulary Status :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
For patients unable to take tablets.
Iodine 5%, potassium iodide 10% (130mg/ml iodine)
Formulary Status :
Indication :
Status :
Formulations :
- Inhaler (Metered Dose)
Restrictions / Comments:
Important
No added benefit in patient's on LAMA.
Not for initiation in new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhaler (Metered Dose)
Restrictions / Comments:
Important
Specialist paediatric recommendation.
Formulary Status :
Indication :
Status :
Formulations :
- Nebules
Restrictions / Comments:
Important
Specialist* recommendation following patient initiation and education on nebuliser therapy, unless for administration as PSD in practice for acute attack.
* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Nebules
Restrictions / Comments:
Important
Specialist recommendation following patient initiation and education on nebuliser therapy, unless for administration as PSD in practice for acute attack.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Nasal spray
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Nasal spray
- Sublingual spray
Restrictions / Comments:
Important
Nasal spray applied sublingually. Off-label use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhaler (Metered Dose)
- Sublingual spray
Restrictions / Comments:
Important
Metered dose inhaler applied sublingually. Off-label use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Nebules
Restrictions / Comments:
Important
Specialist recommendation following patient initiation and education on nebuliser therapy
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Primary care prescribers are not expected to have the clinical expertise to prescribe these devices and should therefore not be asked to prescribe until a formal evaluation and recommendations have been submitted to the APC. Contact pharmacy for advice.
Formulary Status :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
MHRA alert: Hydrochlorothiazide risk of non-melanoma skin cancer
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
- Intravenous infusion
- Intravenous injection (IV)
Restrictions / Comments:
Important
Ferric derisomaltose is preferred.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Intravenous injection (IV)
Restrictions / Comments:
Important
Ferric derisomaltose is preferred.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Initiation and stabilisation by the mental health specialist team for a minimum of 6 months before any transfer of care.
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Liaise with Chest Physician. Patients with multi-drug resistant TB should be treated by a specialist centre.
Formulary Status :
Indication :
Status :
Formulations :
- Cartridges
Restrictions / Comments:
Important
Initiation by diabetes team only. Usage is low but available for existing patients
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
Restrictions / Comments:
Important
Prescribe by brand and state form.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Vials
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Vials
Restrictions / Comments:
Important
Prescribe by brand and state form.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Indication :
Status :
Formulations :
- Modified release tablets
- Tablets
Restrictions / Comments:
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Twice daily (assymetric) dosing is recommended
Formulary Status :
Indication :
Status :
Formulations :
- Modified release capsules
- Modified release tablets
Restrictions / Comments:
Important
Restricted to when isosorbide mononitrate standard release is not suitable.
Primary Care prescribers should follow local advice on the most cost-effective brands. OptimiseRx will be used to identify current recommendations.
Formulary Status :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Important information and resources relating to the Pregnancy Prevention Programme and neuropsychiatric disorders are available on PAD (click drug name to see the PAD page for isotretinoin)
Formulary Status :
Indication :
Status :
Formulations :
- Sachets (granules)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted to cardiology. Specialist initiation and at least one month supply before transfer to primary care
Formulary Status :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted to initiation by cardiology only. Transfer of prescribing to primary care only after initiation and at least the first month supply from the specialist.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE Specialist Commissioned Services only
Formulary Status :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE Specialist Commissioned Services only
Formulary Status :
Indication :
Status :
Formulations :
- Cream
Restrictions / Comments:
Important
Preferred
For mild to moderate rosacea as per CKS.
Formulary Status :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Dermatology specialist team only.
Formulary Status :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :